Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00577-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Amuza Byaruhanga Lucky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA. Hauptthemen laut MEDLINE: Artemisinins, Malaria, Falciparum, Antimalarials. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Startup fund from Morsani College of Medicne, University of South Florida.
Abstract (Originalsprache)
Plasmodium falciparum causes the most severe malaria and is exposed to various environmental and physiological stresses in the human host. Given that GCN5 plays a critical role in regulating stress responses in model organisms, we aimed to elucidate PfGCN5’s function in stress responses in P. falciparum . The protein level of PfGCN5 was substantially induced under three stress conditions [heat shock, low glucose starvation, and dihydroartemisinin, the active metabolite of artemisinin (ART)]. With a TetR-DOZI conditional knockdown (KD) system, we successfully down-regulated PfGCN5 to ~50% and found that KD parasites became more sensitive to all three stress conditions. Transcriptomic analysis via RNA-seq identified ~1,000 up- and down-regulated genes in the wild-type (WT) and KD parasites under these stress conditions. Importantly, DHA induced transcriptional alteration of many genes involved in many aspects of stress responses, which were heavily shared among the altered genes under heat shock and low glucose conditions, including ART-resistance-related genes such as K13 and coronin . Based on the expression pattern between WT and KD parasites under three stress conditions, ~300–400 genes were identified to be involved in PfGCN5-dependent, general, and stress-condition-specific responses with high levels of overlaps among three stress conditions. Notably, using ring-stage survival assay, we found that KD or inhibition of PfGCN5 could sensitize the ART-resistant parasites to the DHA treatment. All these indicate that PfGCN5 is pivotal in regulating general and ART-resistance-related stress responses in malaria parasites, implicating PfGCN5 as a potential target for malaria intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.
- Center for Global Health and Infectious Diseases Research, College of Public Health, University of South Florida , Tampa, Florida, USA.
ORCID-Profile: Jun Miao
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Startup fund from Morsani College of Medicne, University of South Florida
Zitieren
APA
Lucky, A. B., Wang, C., Shakri, A. R., Kalamuddin, M., Chim-Ong, A., Li, X., & Miao, J. (2023). Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00577-23
Vancouver
Lucky AB, Wang C, Shakri AR, Kalamuddin M, Chim-Ong A, Li X, et al. Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00577-23
BibTeX
@article{Lucky2023,
author = {Lucky, Amuza Byaruhanga and Wang, Chengqi and Shakri, Ahmad Rushdi and Kalamuddin, Mohammad and Chim-Ong, Anongruk and Li, Xiaolian and Miao, Jun},
title = {Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00577-23}
}
EUVIMED